Home Healthcare IT Digital Pills Market

Digital Pills Market Size, Share & Trends Analysis Report By Indicated Disorders (Tracking Ingestion in Schizophrenia Patients, Tracking Ingestion in Bipolar Patients, Adjunctive treatment of MDD (major depressive disorder) in adults), By End-Users (Hospitals, Clinic, Home Care Settings) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SRHI37DR | Pages: 155
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Regulatory Framework
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  7. ESG Trends
  8. Global Digital Pills Market Size Analysis
    1. Global Digital Pills Market Introduction
    2. By Indicated Disorders
      1. Introduction
        1. Indicated Disorders By Value
      2. Tracking Ingestion in Schizophrenia Patients
        1. By Value
      3. Tracking Ingestion in Bipolar Patients
        1. By Value
      4. Adjunctive treatment of MDD (major depressive disorder) in adults
        1. By Value
    3. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Clinic
        1. By Value
      4. Home Care Settings
        1. By Value
  9. North America Market Analysis
    1. Introduction
    2. By Indicated Disorders
      1. Introduction
        1. Indicated Disorders By Value
      2. Tracking Ingestion in Schizophrenia Patients
        1. By Value
      3. Tracking Ingestion in Bipolar Patients
        1. By Value
      4. Adjunctive treatment of MDD (major depressive disorder) in adults
        1. By Value
    3. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Clinic
        1. By Value
      4. Home Care Settings
        1. By Value
    4. U.S.
      1. By Indicated Disorders
        1. Introduction
          1. Indicated Disorders By Value
        2. Tracking Ingestion in Schizophrenia Patients
          1. By Value
        3. Tracking Ingestion in Bipolar Patients
          1. By Value
        4. Adjunctive treatment of MDD (major depressive disorder) in adults
          1. By Value
      2. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Clinic
          1. By Value
        4. Home Care Settings
          1. By Value
    5. Canada
  10. Europe Market Analysis
    1. Introduction
    2. By Indicated Disorders
      1. Introduction
        1. Indicated Disorders By Value
      2. Tracking Ingestion in Schizophrenia Patients
        1. By Value
      3. Tracking Ingestion in Bipolar Patients
        1. By Value
      4. Adjunctive treatment of MDD (major depressive disorder) in adults
        1. By Value
    3. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Clinic
        1. By Value
      4. Home Care Settings
        1. By Value
    4. U.K.
      1. By Indicated Disorders
        1. Introduction
          1. Indicated Disorders By Value
        2. Tracking Ingestion in Schizophrenia Patients
          1. By Value
        3. Tracking Ingestion in Bipolar Patients
          1. By Value
        4. Adjunctive treatment of MDD (major depressive disorder) in adults
          1. By Value
      2. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Clinic
          1. By Value
        4. Home Care Settings
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
  11. APAC Market Analysis
    1. Introduction
    2. By Indicated Disorders
      1. Introduction
        1. Indicated Disorders By Value
      2. Tracking Ingestion in Schizophrenia Patients
        1. By Value
      3. Tracking Ingestion in Bipolar Patients
        1. By Value
      4. Adjunctive treatment of MDD (major depressive disorder) in adults
        1. By Value
    3. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Clinic
        1. By Value
      4. Home Care Settings
        1. By Value
    4. China
      1. By Indicated Disorders
        1. Introduction
          1. Indicated Disorders By Value
        2. Tracking Ingestion in Schizophrenia Patients
          1. By Value
        3. Tracking Ingestion in Bipolar Patients
          1. By Value
        4. Adjunctive treatment of MDD (major depressive disorder) in adults
          1. By Value
      2. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Clinic
          1. By Value
        4. Home Care Settings
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
  12. Middle East and Africa Market Analysis
    1. Introduction
    2. By Indicated Disorders
      1. Introduction
        1. Indicated Disorders By Value
      2. Tracking Ingestion in Schizophrenia Patients
        1. By Value
      3. Tracking Ingestion in Bipolar Patients
        1. By Value
      4. Adjunctive treatment of MDD (major depressive disorder) in adults
        1. By Value
    3. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Clinic
        1. By Value
      4. Home Care Settings
        1. By Value
    4. UAE
      1. By Indicated Disorders
        1. Introduction
          1. Indicated Disorders By Value
        2. Tracking Ingestion in Schizophrenia Patients
          1. By Value
        3. Tracking Ingestion in Bipolar Patients
          1. By Value
        4. Adjunctive treatment of MDD (major depressive disorder) in adults
          1. By Value
      2. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Clinic
          1. By Value
        4. Home Care Settings
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
  13. LATAM Market Analysis
    1. Introduction
    2. By Indicated Disorders
      1. Introduction
        1. Indicated Disorders By Value
      2. Tracking Ingestion in Schizophrenia Patients
        1. By Value
      3. Tracking Ingestion in Bipolar Patients
        1. By Value
      4. Adjunctive treatment of MDD (major depressive disorder) in adults
        1. By Value
    3. By End-Users
      1. Introduction
        1. End-Users By Value
      2. Hospitals
        1. By Value
      3. Clinic
        1. By Value
      4. Home Care Settings
        1. By Value
    4. Brazil
      1. By Indicated Disorders
        1. Introduction
          1. Indicated Disorders By Value
        2. Tracking Ingestion in Schizophrenia Patients
          1. By Value
        3. Tracking Ingestion in Bipolar Patients
          1. By Value
        4. Adjunctive treatment of MDD (major depressive disorder) in adults
          1. By Value
      2. By End-Users
        1. Introduction
          1. End-Users By Value
        2. Hospitals
          1. By Value
        3. Clinic
          1. By Value
        4. Home Care Settings
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
  14. Competitive Landscape
    1. Digital Pills Market Share By Players
    2. M&A Agreements & Collaboration Analysis
  15. Market Players Assessment
    1. Proteus Digital Health Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Leaf Healthcare
    3. Intellicap
    4. Perficient Inc.
    5. Microchips Biotech Inc.
    6. Metronic
    7. CapsoVision
    8. Livongo Health
    9. AliveCor Inc.
    10. WellDoc Inc.
    11. Omada Health Inc.
    12. Novartis AG
    13. Abbott
    14. Mocacare
    15. Gentag Inc.
    16. iRhythm Technologies Inc.
  16. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  17. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  18. Disclaimer
Get This Report

Download Free Sample

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.